Literature DB >> 24107451

Neurotrophic keratitis.

F Semeraro1, E Forbice, V Romano, M Angi, M R Romano, M E Filippelli, R Di Iorio, C Costagliola.   

Abstract

Neurotrophic keratitis (NK) is a rare degenerative corneal disease that occurs as a result of partial or total impairment of trigeminal innervations, leading to a reduction (hypoesthesia) in or loss (anaesthesia) of corneal sensitivity. The impairment of sensory innervation causes a reduction in the lacrimation reflex and the vitality, metabolism and mitosis of epithelial cells, with subsequent deficiency in epithelial repair, stromal and intracellular oedema, loss of microvilli, and abnormal development of the basal lamina. Several recent studies have proposed different therapies based on different aetiopathogenetic theories. The aim of the therapy is to treat aetiopathogenesis and, at the same time, promote corneal healing. In this paper, we report the aetiology, diagnosis, management, and medical and surgical treatment of NK, also indicating future treatments based on the most recent studies.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 24107451     DOI: 10.1159/000354380

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  27 in total

1.  Corneal nerve regeneration after herpes simplex keratitis: A longitudinal in vivo confocal microscopy study.

Authors:  Hamid-Reza Moein; Ahmad Kheirkhah; Rodrigo T Muller; Andrea C Cruzat; Deborah Pavan-Langston; Pedram Hamrah
Journal:  Ocul Surf       Date:  2018-01-03       Impact factor: 5.033

Review 2.  Corneal Involvement in Wallenberg Syndrome: Case Report and Literature Review.

Authors:  Francesco Pellegrini; Emanuela Interlandi; Alessandra Cuna; Erika Mandarà; Andrew G Lee
Journal:  Neuroophthalmology       Date:  2019-04-08

3.  Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops.

Authors:  Ronald Mauricio Sanchez-Avila; Jesus Merayo-Lloves; Ana Cristina Riestra; Luis Fernandez-Vega Cueto; Eduardo Anitua; Leire Begoña; Francisco Muruzabal; Gorka Orive
Journal:  Int Ophthalmol       Date:  2017-06-15       Impact factor: 2.031

4.  In vitro 3D corneal tissue model with epithelium, stroma, and innervation.

Authors:  Siran Wang; Chiara E Ghezzi; Rachel Gomes; Rachel E Pollard; James L Funderburgh; David L Kaplan
Journal:  Biomaterials       Date:  2016-10-04       Impact factor: 12.479

Review 5.  Corneal epithelial cells function as surrogate Schwann cells for their sensory nerves.

Authors:  Mary Ann Stepp; Gauri Tadvalkar; Raymond Hakh; Sonali Pal-Ghosh
Journal:  Glia       Date:  2016-11-23       Impact factor: 7.452

6.  Reversible nerve damage and corneal pathology in murine herpes simplex stromal keratitis.

Authors:  Hongmin Yun; Alexander M Rowe; Kira L Lathrop; Stephen A K Harvey; Robert L Hendricks
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

7.  Curative effect assessment of bandage contact lens in neurogenic keratitis.

Authors:  Yu-Zhao Sun; Lei Guo; Fu-Sheng Zhang
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

8.  Characteristics of the ocular surface in neurotrophic keratitis induced by trigeminal nerve injury following neurosurgery.

Authors:  Caiyuan Xie; Bo Liu; Xiaoyu Zhao; Qing He; Lin Liu; Ruihua Wei
Journal:  Int Ophthalmol       Date:  2022-09-17       Impact factor: 2.029

9.  Impact of adjuvant amniotic membrane transplantation in infectious ulcerative keratitis.

Authors:  Okyanus Bulut; Gunel Musayeva; Ozlem Barut Selver
Journal:  Int Ophthalmol       Date:  2022-09-07       Impact factor: 2.029

Review 10.  Topical delivery of nerve growth factor for treatment of ocular and brain disorders.

Authors:  Gemma Eftimiadi; Marzia Soligo; Luigi Manni; Daniela Di Giuda; Maria Lucia Calcagni; Antonio Chiaretti
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.